SDC 3 - Figure S2 % of splenic CD4+CD25+Foxp3+ T cells d8 d15 d20.

Slides:

Advertisements

Similar presentations

Supplementary Figure S1.

Advertisements

Dipeptidyl peptidase IV (DPPIV/CD26) inhibition does not improve engraftment of unfractionated syngeneic or allogeneic bone marrow after nonmyeloablative.

Fig. 6. Expression of CD69 and CD25 under vitamin C treatment at various times before and after activation. Human T cells (5×105 cells/well) were cultured.

Foxp3+ Regulatory T Cells and Natural Killer Cells Distinctly Infiltrate Primary Tumors and Draining Lymph Nodes in Pulmonary Adenocarcinoma Thomas Schneider,

Molecular Therapy - Methods & Clinical Development

Volume 42, Issue 2, Pages (February 2015)

Volume 80, Issue 2, Pages (July 2011)

The Humoral Immune Response Is Initiated in Lymph Nodes by B Cells that Acquire Soluble Antigen Directly in the Follicles Kathryn A. Pape, Drew M. Catron,

Juyang Kim, Wongyoung Kim, Hyun J. Kim, Sohye Park, Hyun-A

Anti–4-1BB/PD-1 combination enriched CD8+ T cells in TILs

Yumi Matsuzaki, Kentaro Kinjo, Richard C Mulligan, Hideyuki Okano

Matthew C. Tunis, BSc, Wojciech Dawicki, PhD, Kaitlyn R

Crosstalk of regulatory T cells and tolerogenic dendritic cells prevents contact allergy in subjects with low zone tolerance Ulrike Luckey, PhD, Talkea.

by Sheng F. Cai, Xuefang Cao, Anjum Hassan, Todd A

CCR10 regulates balanced maintenance and function of resident regulatory and effector T cells to promote immune homeostasis in the skin Mingcan Xia,

Volume 18, Issue 1, Pages (January 2017)

IL-6 Blockade Attenuates the Development of Murine Sclerodermatous Chronic Graft- Versus-Host Disease Doanh Le Huu, Takashi Matsushita, Guihua Jin, Yasuhito.

Figure 1 Treg percentage and suppressive function increased during each round of Treg infusions Treg percentage and suppressive function increased during.

Shilpak Chatterjee, Jonathan M. Eby, Amir A

Volume 42, Issue 5, Pages (May 2015)

SDC 2 - Figure S1.

Preventing Allograft Rejection by Targeting Immune Metabolism

Volume 62, Issue 6, Pages (December 2002)

the common cytokine receptor g chain,

The PI3K–Akt pathway is essential for the in vivo maintenance of murine Tregs. The PI3K–Akt pathway is essential for the in vivo maintenance of murine.

Volume 28, Issue 3, Pages (September 2015)

Forkhead box protein 3 demethylation is associated with tolerance induction in peanut- induced intestinal allergy Meiqin Wang, MD, PhD, Ivana V. Yang,

Dipeptidyl peptidase IV (DPPIV/CD26) inhibition does not improve engraftment of unfractionated syngeneic or allogeneic bone marrow after nonmyeloablative.

Foxp3+ Regulatory T Cells and Natural Killer Cells Distinctly Infiltrate Primary Tumors and Draining Lymph Nodes in Pulmonary Adenocarcinoma Thomas Schneider,

Fig. 5 A competent Fc is required for the antitumor immune response.

Volume 17, Issue 12, Pages (December 2016)

Volume 23, Issue 3, Pages (March 2013)

Blocking Activator Protein 1 Activity in Donor Cells Reduces Severity of Acute Graft- Versus-Host Disease through Reciprocal Regulation of IL-17–Producing.

Volume 28, Issue 5, Pages (May 2008)

Volume 21, Issue 7, Pages (November 2017)

Volume 24, Issue 6, Pages (August 2018)

CD22 is a negative regulator of B-cell receptor signalling

Gilbert R. Kinsey, Liping Huang, Amy L. Vergis, Li Li, Mark D. Okusa

Host Basophils Are Dispensable for Induction of Donor T Helper 2 Cell Differentiation and Severity of Experimental Graft-versus-Host Disease Isao Tawara,

Molecular Therapy - Methods & Clinical Development

FGF-2 signaling mediates expansion of HSPCs

Supplemental Digital Content 2 – Figure 1

Volume 136, Issue 3, Pages e2 (March 2009)

Recipient B Cells Are Not Required for Graft-Versus-Host Disease Induction Catherine Matte-Martone, Xiajian Wang, Britt Anderson, Dhanpat Jain, Anthony.

Volume 141, Issue 5, Pages (November 2011)

Volume 17, Issue 2, Pages (February 2009)

Fig. 4. Dabrafenib and trametinib changed the cellular components of the tumor microenvironment. Dabrafenib and trametinib changed the cellular components.

Volume 19, Issue 7, Pages (July 2011)

Intravenous immunoglobulin attenuates airway inflammation through induction of forkhead box protein 3–positive regulatory T cells Amir H. Massoud, MSc,

In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti- factor VIII Immune Responses in Hemophilia A Mice Treated With Factor.

Volume 37, Issue 5, Pages (November 2012)

Treatment with AZD5363 reduces the proportion of proliferating vascular endothelial cells and following RT, the influx of CD11b+ bone marrow‐derived cells.

Volume 62, Issue 1, Pages (July 2002)

Volume 84, Issue 1, Pages (July 2013)

Volume 31, Issue 6, Pages (December 2009)

Supplementation of c-Rel–competent Treg cells reverts exacerbated diabetes in c-Rel−/− NOD mice. Supplementation of c-Rel–competent Treg cells reverts.

Volume 10, Issue 11, Pages (March 2015)

Volume 30, Issue 2, Pages (February 2009)

Epicutaneous immunization with ovalbumin and CpG induces TH1/TH17 cytokines, which regulate IgE and IgG2a production Monika Majewska-Szczepanik, PhD,

Combination CDN and PD-L1 mAb treatment of established MOC1 tumors produces consistent tumor rejection. Combination CDN and PD-L1 mAb treatment of established.

Treg expression of Gata3 plays a major role in controlling dermal fibrosis. Treg expression of Gata3 plays a major role in controlling dermal fibrosis.

Crebbp deficiency accelerates B-cell lymphoma development in mice.

DAC treatment alters immune cell composition and enhances cytokine production in the peritoneal lavage. DAC treatment alters immune cell composition and.

Depletion of Gr-1+ neutrophils by systemic anti-Gr-1 treatment prevents exacerbated neurodegeneration in RAG1-KO mice. Depletion of Gr-1+ neutrophils by.

Immunophenotypic analysis of TILs in B16 and K1735 melanoma following combination therapy with antibodies targeting PS and PD-1. Immunophenotypic analysis.

Tumor protection induced by therapeutic PLG vaccination in combination with blockade antibodies. Tumor protection induced by therapeutic PLG vaccination.

PDL192 and inhibit the growth of xenograft tumors.

Mice with a B cell–specific deletion of Ets1 do not have increased CD4+ T cell activation. Mice with a B cell–specific deletion of Ets1 do not have increased.

Volume 45, Issue 5, Pages (November 2016)

Bb monocolonization enhances Treg population in the cLP.

Presentation transcript:

SDC 3 - Figure S2 % of splenic CD4+CD25+Foxp3+ T cells d8 d15 d20

SDC 3 - Figure S2. Changes in the percentage of splenic CD4+CD25+Foxp3+ T cells in untreated recipients and those receiving FR70, IgG1 or IgG2a antibody treatment at various timepoints post-transplantation. Antibody staining and flow cytometric analysis was performed to determine the percent of splenic CD4+CD25+Foxp3+ T regulatory cells (Tregs) in all treatment groups. A single dot in the scatter plot represents the percent of splenic Tregs in a single mouse in that group and time point. Each group has n=3-6 mice. Untreated controls had a greater percentage of Tregs at day 8 post-transplantation compared with FR70, IgG1 and IgG2a treatment. No significant change was seen in the percent of Tregs at days 15 and 20 in all treated groups. All untreated mice rejected before day 15 and IgG1 treated mice rejected before day 20 therefore splenic Tregs could not be analysed at these time points for the corresponding group.